NCT02925637

Brief Summary

To develop and assess the effectiveness of a novel cognitive-functional intervention (FACoT) in occupational therapy for people after mild to moderate stroke.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Mar 2017

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 3, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 6, 2016

Completed
5 months until next milestone

Study Start

First participant enrolled

March 12, 2017

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 27, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 27, 2020

Completed
Last Updated

April 14, 2021

Status Verified

February 1, 2019

Enrollment Period

3 years

First QC Date

August 3, 2016

Last Update Submit

April 11, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in scores of The Canadian Occupational Performance Measure (COPM)

    Change between baseline (week 0) to time 1 (post-intervention -10-13 weeks later) and time 2 (follow-up- three month later)

Secondary Outcomes (11)

  • Change in scores of the Instrumental Activities of Daily Living (IADL) scale

    Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later)

  • Change in scores of Reintegration to Normal Living Index (RNL)

    Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up-3 month later)

  • Change in scores of Short Form-12v2 Health Survey (SF-12v2)

    Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later)

  • change in scoe of New general self efficacy scale (NGSE)

    Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later)

  • Change in scores of Patient competency rating scale (PCRS)

    Change between baseline (week 0) to time 1 (post-intervention, 10-13 weeks later) and between baseline to time 2 (follow-up- 3 month later)

  • +6 more secondary outcomes

Other Outcomes (3)

  • National Institutes of Health Stroke Scale (NIHSS)

    baseline (week 0)

  • Functional Independence Measure (FIM)

    baseline (week 0)

  • demographic questionnaire

    baseline (week 0)

Study Arms (2)

FACoT group

EXPERIMENTAL

treatment group will receive FACoT, that include one to one 10 treatment sessions. the treatment sessions will include: functional activities, cognitive activities and strategies (pencil-pen treatment), and behavioural strategies

Other: FaCoT

control group

NO INTERVENTION

control group receiving standard care - cognitive and functional assesment

Interventions

FaCoTOTHER

The intervention will include: functional activities, cognitive activities and strategies (pencil-pen treatment), and behavioural strategies

FACoT group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>18 years
  • at least three years post stroke
  • severity mild to moderate (NIHSS≤5)
  • independent prior to the stroke
  • can understand and speak Hebrew

You may not qualify if:

  • with no other neurological or psychiatric conditions
  • without dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maccabi

Ashdod, Israel

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • tal adamit, PHD student

    Maccabbi health center ashdod isreal

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2016

First Posted

October 6, 2016

Study Start

March 12, 2017

Primary Completion

February 27, 2020

Study Completion

February 27, 2020

Last Updated

April 14, 2021

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

Locations